Corcept Therapeutics Inc (NASDAQ:CORT)

21.50
Delayed Data
As of Nov 26
 -0.96 / -4.27%
Today’s Change
17.57
Today|||52-Week Range
31.18
-17.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues50.3M81.3M159.2M251.2M
 
 
 
 
 
Cost of Goods Sold1.2M2.0M3.4M5.0M
 
 
 
 
 
Depreciation And Amortization155.0K87.0K106.0K236.0K
 
 
 
 
 
 
Operating ExpensesGross Income48.9M79.3M155.6M246.0M
 
 
 
 
 
General Expenses52.4M69.1M102.8M156.5M
 
 
 
 
 
Research And Development15.4M23.8M40.4M75.2M
 
 
 
 
 
Total Operating Expenses53.7M71.1M106.3M161.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M10.2M52.9M89.5M
 
 
 
 
 
Interest Expense On Debt2.8M1.9M456.0K0.00
 
 
 
 
Other Expenses-165.0K-110.0K407.0K2.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.4M8.1M52.8M92.2M
 
 
 
 
 
Income Taxes0.000.00-76.3M-16.7M
 
 
 
Net Income-6.4M8.1M129.1M75.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS106.9M110.6M113.5M115.3M
 
 
 
 
 
Shares To Calculate EPS Diluted106.9M110.6M124.5M126.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06$0.07$1.04$0.60
 
 
 
 
 
EPS Diluted-$0.06$0.07$1.04$0.60